首页> 外文期刊>Drugs: International Journal of Current Therapeutics and Applied Pharmacology Reviews, Featuring Evaluations on New Drugs, Review Articles on Drugs and Drug Therapy, and Drug Literature Abstracts >Comment on: Progression-Free Survival as a Surrogate for Overall Survival in Clinical Trials of Targeted Therapy in Advanced Solid Tumors

【24h】

Comment on: Progression-Free Survival as a Surrogate for Overall Survival in Clinical Trials of Targeted Therapy in Advanced Solid Tumors

机译：评论：进展生存作为晚期实体肿瘤的临床试验中临床试验的整体存活的替代物

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Drugs: International Journal of Current Therapeutics and Applied Pharmacology Reviews, Featuring Evaluations on New Drugs, Review Articles on Drugs and Drug Therapy, and Drug Literature Abstracts》 |2017年第10期|共2页
作者
Schoenfeld David A.;
展开▼
作者单位

Massachusetts Gen Hosp Biostat Ctr 50 Staniford St Boston MA 02114 USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类药学;
关键词

相似文献

外文文献
中文文献
专利

1. Comment on: Progression-Free Survival as a Surrogate for Overall Survival in Clinical Trials of Targeted Therapy in Advanced Solid Tumors [J] . Schoenfeld David A. Drugs: International Journal of Current Therapeutics and Applied Pharmacology Reviews, Featuring Evaluations on New Drugs, Review Articles on Drugs and Drug Therapy, and Drug Literature Abstracts . 2017,第10期

机译：评论：进展生存作为晚期实体肿瘤的临床试验中临床试验的整体存活的替代物
2. Progression-Free Survival as a Surrogate for Overall Survival in Clinical Trials of Targeted Therapy in Advanced Solid Tumors [J] . Michiels Stefan, Saad Everardo D., Buyse Marc Drugs: International Journal of Current Therapeutics and Applied Pharmacology Reviews, Featuring Evaluations on New Drugs, Review Articles on Drugs and Drug Therapy, and Drug Literature Abstracts . 2017,第7期

机译：进展的生存作为临床试验在先进实体肿瘤中的临床试验中的整体存活的替代物
3. Authors' Reply to Schoenfeld: "Progression-Free Survival as a Surrogate for Overall Survival in Clinical Trials of Targeted Therapy in Advanced Solid Tumors" [J] . Michiels Stefan, Saad Everardo D., Buyse Marc Drugs: International Journal of Current Therapeutics and Applied Pharmacology Reviews, Featuring Evaluations on New Drugs, Review Articles on Drugs and Drug Therapy, and Drug Literature Abstracts . 2017,第10期

机译：作者回复Schoenfeld：“无进展生存，作为临床试验在先进实体肿瘤中临床试验中的替代物的替代物”
4. Association between tumor heterogeneity and progression-free survival in non-small cell lung cancer patients with EGFR mutations undergoing tyrosine kinase inhibitors therapy [C] . Jiangdian Song, Di Dong, Yanqi Huang, Annual International Conference of the IEEE Engineering in Medicine and Biology Society . 2016

机译：接受酪氨酸激酶抑制剂治疗的EGFR突变非小细胞肺癌患者肿瘤异质性与无进展生存的关系
5. Statistical Models to Capture the Association Between Progression-Free and Overall Survival in Oncology Trials [D] . Weber, Enya Maria. 2020

机译：统计模型捕获肿瘤学试验无进展和整体生存之间的关联
6. Magnitude of the Benefit of Progression-Free Survival as a Potential Surrogate Marker in Phase 3 Trials Assessing Targeted Agents in Molecularly Selected Patients with Advanced Non-Small Cell Lung Cancer: Systematic Review [O] . Katsuyuki Hotta, Yuka Kato, Natasha Leighl, -1

机译：无进展生存作为潜在替代指标在评估晚期非小细胞肺癌分子选择患者的靶向药物的3期试验中的潜在替代指标的数量级：系统评价
7. Progression-free survival as surrogate end point for overall survival in clinical trials of HER2-targeted agents in HER2-positive metastatic breast cancer [O] . S. Michiels, L. Pugliano, S. Marguet, 2016

机译：无进展的生存作为HER2阳性转移乳腺癌临床试验临床试验中的替代终点

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

客服微信
服务号